Key result
Nanoparticle-delivered AG1295 reduces intima/media ratio ~40% and limits luminal narrowing in porcine arteries.
Why the study?
Signaling through protein tyrosine kinases is a major contributor to smooth muscle cell growth and neointimal formation after vascular injury, and the effect of the selective PDGF-receptor PTK blocker AG1295 on these processes was unknown.
Does local delivery of the PDGF-receptor tyrosine kinase blocker AG1295 reduce neointimal formation after balloon angioplasty in a swine model?
Does local delivery of the PDGF-receptor tyrosine kinase blocker AG1295 reduce neointimal formation after balloon angioplasty in a swine model?
Answers are grounded in this paper and cite their sources.
Targeting PDGF-receptor kinase with nanoparticle-delivered AG1295 significantly inhibits smooth muscle cell proliferation and reduces neointimal formation after balloon injury in a swine model, representing a potential strategy against restenosis.
Background —Signaling through protein tyrosine kinases (PTKs) is a major contributor to the transmission of mitogenic stimuli to the interior of the cell and nucleus. The present study was designed to determine the effect of the tyrphostin AG1295, a selective blocker of PDGF-receptor PTK, on the growth of porcine and human smooth muscle cells (SMCs) in culture, on the outgrowth kinetics of SMCs from porcine and human arterial explants, and on neointimal formation after balloon injury in pigs. Methods and Results —SMCs for culture were obtained from porcine abdominal aortas, human internal mammary arteries, and endarterectomy tissue from a single human carotid artery. Addition of AG1295 to SMCs before PDGF stimulation completely inhibited PDGF-β-receptor tyrosine phosphorylation without affecting the level of PDGF-β-receptor. AG1295 resulted in a selective, reversible inhibition of SMC proliferation in culture (76%) with only mild (13.5%) inhibition of endothelial cell proliferation. The number of SMCs accumulating around explants of porcine carotid arteries and human endarterectomy specimens 12, 15, 19, 22, and 24 days after plating was reduced by 82% to 92% in AG1295-treated compared with nontreated specimens, and initiation of SMC outgrowth was markedly delayed. The numbers of cells accumulated 10 days after initiation of outgrowth were significantly lower in treated versus control explants. Local intravascular delivery of AG1295-impregnated polylactic acid–based nanoparticles (130±25 nm) to the site of balloon injury to porcine femoral arteries resulted in significant reductions in intima/media area ratio and luminal cross-sectional area narrowing by neointima compared with contralateral control arteries to which empty nanoparticles were applied (0.15±0.07 versus 0.09±0.03, P =.046 and 20±4% versus 10±4%, P =.0009, n=6 for both). Conclusions —The tyrphostin AG1295, a selective blocker of PDGF-receptor kinase, exerts a marked inhibitory effect on the activation, migration, and proliferation of porcine and human SMCs in vitro and an ≈50% inhibitory effect on neointimal formation after balloon injury in porcine femoral arteries when delivered via biodegradable nanoparticles. Further studies appear to be warranted to evaluate the applicability of this novel approach to the interventional setting.
No takes yet. Share an insight, caveat, or question.
Banai et al. (1998) studied Neointimal formation after balloon angioplasty (n=6). AG1295-impregnated polylactic acid-based nanoparticles vs. Empty nanoparticles was evaluated on Intima/media area ratio (p=0.046). Local intravascular delivery of AG1295-impregnated nanoparticles reduced intima/media area ratio and luminal narrowing in porcine arteries.
Synapse has enriched 10 related papers. Consider them for comparative context: